Max Healthcare Institute Ltd
MAXHEALTH
Rank in Stocks
#2276
Max Healthcare Institute Limited provides medical and healthcare services in... Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Share Price
$9.02
Market Cap
$8.78B
Change (1 day)
-1.52%
Change (1 year)
-34.05%
Country
IN
Trade Max Healthcare Institute Ltd (MAXHEALTH)
Category
Healthcare
P/E ratio for Max Healthcare Institute Ltd (MAXHEALTH)
P/E ratio as of October 2026 TTM: 57.76
According to Max Healthcare Institute Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 57.76. At the end of 2024 the company had a P/E ratio of 75.05.
P/E ratio history for Max Healthcare Institute Ltd from 2014 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 57.76 | -41.32% |
| 2025 | 98.42 | 31.15% |
| 2024 | 75.05 | 93.54% |
| 2023 | 38.78 | -30.25% |
| 2022 | 55.59 | -143.05% |
| 2021 | -129.12 | -291.58% |
| 2020 | 67.40 | -103.38% |
| 2019 | -1.99K | 854.56% |
| 2018 | -208.95 | -131.54% |
| 2017 | 662.60 | -345.66% |
| 2016 | -269.72 | 105.16% |
| 2015 | -131.47 | 84.92% |
| 2014 | -71.10 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 15.70 | -72.81% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -82.00% |
US
|
|
| 32.07 | -44.47% |
SA
|
|
| 20.00 | -65.37% |
BR
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.